BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15306032)

  • 1. Hürthle cell carcinoma: diagnostic and therapeutic implications.
    Hanief MR; Igali L; Grama D
    World J Surg Oncol; 2004 Aug; 2():27. PubMed ID: 15306032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.
    Sanders LE; Silverman M
    Surgery; 1998 Dec; 124(6):967-74. PubMed ID: 9854570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An unusual case of hürthle cell carcinoma presenting as metastatic pleural disease 16 years after thyroidectomy.
    Bagherzadegan N; Feller-Kopman D; Ernst A; Haerle S; Lunn W
    J Bronchology Interv Pulmonol; 2009 Jul; 16(3):204-6. PubMed ID: 23168555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy?
    McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A
    Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine-needle aspiration cytology of Hürthle cell carcinoma of the thyroid.
    Wu HH; Clouse J; Ren R
    Diagn Cytopathol; 2008 Mar; 36(3):149-54. PubMed ID: 18232004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metastatic Hurthle Cell Carcinoma of the thyroid presenting as a Breast Lump: A Case Report.
    Al-Abed Y; Gray E; Wolfe K; Watters GW; Philpott JM
    Int Semin Surg Oncol; 2008 May; 5():14. PubMed ID: 18505578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hürthle cell carcinoma is a better gold standard than Hürthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria.
    Renshaw AA
    Cancer; 2002 Oct; 96(5):261-6. PubMed ID: 12378592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease.
    Kauffmann PR; Dejax C; de Latour M; Dauplat J
    Eur J Surg Oncol; 2004 Sep; 30(7):786-9. PubMed ID: 15296995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hürthle cell tumors: a twenty-five-year experience.
    Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fine needle aspiration cytology of unsuspected metastatic hurthle cell carcinoma of the thyroid and its pitfalls: a report of two cases.
    Lallu S; Naran S; Bethwaite P
    Diagn Cytopathol; 2007 Jul; 35(7):439-43. PubMed ID: 17580356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed squamous cell carcinoma and follicular carcinoma of the thyroid gland.
    Mercante G; Marchesi A; Covello R; Dainese L; Spriano G
    Auris Nasus Larynx; 2012 Jun; 39(3):310-3. PubMed ID: 21855238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hurthle cell tumor.
    Chen HY; Benjamin LB; Chen MF
    Int Surg; 1996; 81(2):168-70. PubMed ID: 8912085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hurthle cell neoplasms of the thyroid.
    Dahl LD; Myssiorek D; Heller KS
    Laryngoscope; 2002 Dec; 112(12):2178-80. PubMed ID: 12461336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.